ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
rdf:type |
rdfs:Resource |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
rdf:type |
owl:Thing |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
rdf:type |
ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
rdf:type |
tido:Hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
prov:wasAttributedTo |
ripekg:human-reviewer/RV001 |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEACF96EE4CD6A96F4B |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEACF96EE4CD6A96F4B |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
ripe:resultOutcome |
yes |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
tido:answers |
ripekg:integrity-assessment-question/research-team-related-concerns/1.0.01.3. Do other studies by the research team highlight causes for concern? |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |
tido:answers |
ripekg:integrity-assessment-question/research-team-related-concerns/1.0.0research-team-related concerns |
ripekg:retraction-notice/28473Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEACF96EE4CD6A96F4B-human-1-3 |